ArticleCureus2026
Navigating a Dual Hyperinflammatory State: Overlap of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) and Secondary Hemophagocytic Lymphohistiocytosis (HLH) in a Child.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug-induced hypersensitivity reaction with a diverse clinical presentation. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome due to uncontrolled immune activation. Although uncommon, overlap between DRESS and secondary HLH is increasingly reported, particularly in association with viral reactivation such as Epstein-Barr virus (EBV). Both DRESS and HLH can present with multi-organ dysfunction. We present a 12-year-old boy who presented with fever for four weeks and a generalized maculopapular rash for three weeks after the initiation of phenytoin, and a diagnosis of DRESS was made after skin biopsy. Withdrawal of phenytoin and initiation of systemic corticosteroids led to initial clinical improvement, but the clinical course was complicated by secondary HLH due to EBV reactivation. Treatment with dexamethasone and etoposide resulted in recovery of clinical symptoms and normalisation of biochemical parameters. This case underscores the importance of early recognition of HLH in children with DRESS who show clinical deterioration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.